NASDAQ : MLEC
Moolec Science SA — Company profile
Healthcare · Biotechnology · Cayman Islands
Last price 1.4 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 2.91M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Moolec Science SA, a science-based ingredient company, engages in the development of ingredients for food, pet food, animal feed, and dietary supplements using molecular farming technology and precision fermentation platforms in Cayman Islands and internationally. It develops nutritional supplements, food ingredients, meat replacements, and by-products using safflowers, chickpeas, fungi, soybeans, and yeast, as well as lupin and peas. The company is based in Grand Cayman, Cayman Islands.
Details
| Name | Moolec Science SA |
| Sector | Healthcare |
| Industry | Biotechnology |
| Founded | 2008 |
| Ceo | Alejandro Antalich |
| Country | Cayman Islands |
| Exchange | NASDAQ |
| Fiscal Year | July - June |
| Reporting Currency | USD |
| Isin | KYG6223S1259 |
| Cusip | G6223S125 |
| Cik | 1937737 |
| Sic | 2000 |
Key executives
| Name | Title |
|---|---|
| Alejandro Antalich | Chief Executive Officer |
| Henk Hoogenkamp Ph.D. | Co-Founder and Chief Product Officer |
| Martin Salinas Ph.D. | Co-Founder |
| Valeria Falottico | Chief Financial Officer |
| Dr. Paola Díaz Dellavalle | Chief Technology Officer |
| Dr. Amit Dhingra Ph.D. | Chief Science Officer |
| Catalina Jones B.A. | Chief of Staff and Sustainability |
Contact
| Address | 89 Nexus Way, Camana Bay, Grand Cayman, KY1-9009, Cayman Islands |
| Website | https://www.moolecscience.com |